Sandbox reserved 919: Difference between revisions

From Proteopedia
Jump to navigationJump to search
No edit summary
No edit summary
Line 14: Line 14:


The <scene name='58/580297/3dnm_ligandsite_charge_relay/1'>catalytic triad</scene> is comprised of Ser157, Glu251, and His281. The Ser157 residue sits at a site deemed the "nucleophilic elbow," that models an approximate torsion of Φ = 60° and Ψ =-120°. This nucleophilic elbow is stabilized by a hydrogen bond between the proximal nitrogen and oxygen atoms of His281 and Glu251, respectively. This model also shows the Ser157 residue to be stabilized by the covalent binding of <scene name='58/580297/3dnm_cartoon_ligand/2'>β-mercaptoethanol</scene>.  
The <scene name='58/580297/3dnm_ligandsite_charge_relay/1'>catalytic triad</scene> is comprised of Ser157, Glu251, and His281. The Ser157 residue sits at a site deemed the "nucleophilic elbow," that models an approximate torsion of Φ = 60° and Ψ =-120°. This nucleophilic elbow is stabilized by a hydrogen bond between the proximal nitrogen and oxygen atoms of His281 and Glu251, respectively. This model also shows the Ser157 residue to be stabilized by the covalent binding of <scene name='58/580297/3dnm_cartoon_ligand/2'>β-mercaptoethanol</scene>.  
</StructureSection>




Line 27: Line 24:


Inhibition or decreased activity of hormone-sensitive lipases can possibly lead to disorders such as atherosclerosis, obesity, and type 2 diabetes. Inability to break down fatty acid molecules due to inactive hormone-sensitive lipases has been reported in many cases of obesity and type 2 diabetes. Increased inhibition of HSL by PMSF could, in theory, also be a possible cause of these diseases.<ref name="Kraemer">PMID: 12364542 </ref>
Inhibition or decreased activity of hormone-sensitive lipases can possibly lead to disorders such as atherosclerosis, obesity, and type 2 diabetes. Inability to break down fatty acid molecules due to inactive hormone-sensitive lipases has been reported in many cases of obesity and type 2 diabetes. Increased inhibition of HSL by PMSF could, in theory, also be a possible cause of these diseases.<ref name="Kraemer">PMID: 12364542 </ref>
</StructureSection>
==Additional pages about hormone-sensitive lipase==
==Additional pages about hormone-sensitive lipase==
* [http://en.wikipedia.org/wiki/Hormone_sensitive_lipase Hormone-sensitive lipase]
* [http://en.wikipedia.org/wiki/Hormone_sensitive_lipase Hormone-sensitive lipase]

Revision as of 12:02, 1 April 2014

Introduction to hormone-sensitive lipase

File:HPL Movie0006.png
Hormone-Sensitive Lipase

Hormone-sensitive lipases (HSL) represent a class of esterases within the hydrolase family that catalyzes the cleavage of ester bonds in fatty acid molecules when stimulated by a hormone. The activation and mobilization of these hormone-sensitive lipases can be triggered by various catecholamines and inhibited by insulin. HSL is clinically relevant because the mobilization of fats in cells is directly related to fat accumulation seen in artherosclerosis, type 2 diabetes, and obesity. Investigation of HSL's structure and function could provide a better clinical understanding of these diseases. [1]

Briefly, binding of catecholamines to β-adrenergic receptors coupled with adenylate cyclase (AC) stimulates G-proteins to increase the levels of cystolic cAMP. Elevated levels of cAMP leads to an activation protein kinase A (PKA) leading to phosphorylation of serine residues on HSL activating and translocating HSL to lipid droplets for lipolysis. Conversely, insulin signaling decreases cystolic cAMP levels, resulting in a decreased HSL mobilization. [2]


Structure of hormone-sensitive lipase

Hormone-Sensitive Lipase from 3dnm

Drag the structure with the mouse to rotate


Additional pages about hormone-sensitive lipase

References

  1. ↑ Yeaman SJ. Hormone-sensitive lipase--new roles for an old enzyme. Biochem J. 2004 Apr 1;379(Pt 1):11-22. PMID:14725507 doi:https://dx.doi.org/10.1042/BJ20031811
  2. ↑ Holm C. Molecular mechanisms regulating hormone-sensitive lipase and lipolysis. Biochem Soc Trans. 2003 Dec;31(Pt 6):1120-4. PMID:14641008 doi:https://dx.doi.org/10.1042/